中国基层医药
中國基層醫藥
중국기층의약
CHINESE JOURNAL OF PRIMARY MEDICINE AND PHARMACY
2011年
20期
2756-2758
,共3页
张明亮%靖树新%张焕轶
張明亮%靖樹新%張煥軼
장명량%정수신%장환질
舒张性,心力衰竭%阵发性,心房颤动%P波离散度%步长稳心颗粒%老年人
舒張性,心力衰竭%陣髮性,心房顫動%P波離散度%步長穩心顆粒%老年人
서장성,심력쇠갈%진발성,심방전동%P파리산도%보장은심과립%노년인
Diastolic cardiac dysfunction%Paroxysmal atrial defibrillation%Dispersion of P wave%Buchang wenxin particles%Elder patients
目的 研究稳心颗粒对老年舒张性心力衰竭合并阵发性心房颤动(PAF)患者P波最大时限(Pmax)、P波离散度(Pd)的影响。方法 将115例老年舒张性心力衰竭合并PAF患者作为房颤组，随机分为两组：A组56例为常规治疗组，B组59例在常规治疗的基础上加用稳心颗粒。同时以54例老年舒张性心力衰竭不伴PAF患者作为对照组。比较房颤组及无房颤组以及A、B组间治疗前后Pmax及Pd的变化。结果 房颤组Pmax及Pd均高于非房颤组（均P＜0.01），治疗前A、B两组Pmax及Pd差异均无统计学意义（均P＞0.05），治疗后B组房颤发作次数明显减少，Pmax及Pd较治疗前均明显缩短，与A组比较差异均有统 计学意义（均P＜0.01）。结论 老年舒张性心力衰竭合并PAF者较无PAF者Pmax及Pd增大，步长稳心颗粒治疗老年舒张性心力衰竭合并PAF可缩短Pmax及Pd，减少房颤发作次数。
目的 研究穩心顆粒對老年舒張性心力衰竭閤併陣髮性心房顫動(PAF)患者P波最大時限(Pmax)、P波離散度(Pd)的影響。方法 將115例老年舒張性心力衰竭閤併PAF患者作為房顫組，隨機分為兩組：A組56例為常規治療組，B組59例在常規治療的基礎上加用穩心顆粒。同時以54例老年舒張性心力衰竭不伴PAF患者作為對照組。比較房顫組及無房顫組以及A、B組間治療前後Pmax及Pd的變化。結果 房顫組Pmax及Pd均高于非房顫組（均P＜0.01），治療前A、B兩組Pmax及Pd差異均無統計學意義（均P＞0.05），治療後B組房顫髮作次數明顯減少，Pmax及Pd較治療前均明顯縮短，與A組比較差異均有統 計學意義（均P＜0.01）。結論 老年舒張性心力衰竭閤併PAF者較無PAF者Pmax及Pd增大，步長穩心顆粒治療老年舒張性心力衰竭閤併PAF可縮短Pmax及Pd，減少房顫髮作次數。
목적 연구은심과립대노년서장성심력쇠갈합병진발성심방전동(PAF)환자P파최대시한(Pmax)、P파리산도(Pd)적영향。방법 장115례노년서장성심력쇠갈합병PAF환자작위방전조，수궤분위량조：A조56례위상규치료조，B조59례재상규치료적기출상가용은심과립。동시이54례노년서장성심력쇠갈불반PAF환자작위대조조。비교방전조급무방전조이급A、B조간치료전후Pmax급Pd적변화。결과 방전조Pmax급Pd균고우비방전조（균P＜0.01），치료전A、B량조Pmax급Pd차이균무통계학의의（균P＞0.05），치료후B조방전발작차수명현감소，Pmax급Pd교치료전균명현축단，여A조비교차이균유통 계학의의（균P＜0.01）。결론 노년서장성심력쇠갈합병PAF자교무PAF자Pmax급Pd증대，보장은심과립치료노년서장성심력쇠갈합병PAF가축단Pmax급Pd，감소방전발작차수。
Objective To investigate the effect of Buchangwenxin particles in maximum P wave (Pmax), dispersion of P wave(Pd) of elder patients with diastolic cardiac dysfunction and paroxysmal atrial fibrillation(PAF).Methods 115 elder patients with diastolic cardiac dysfunction and PAF were randomly divided into two groups:group A received the routine drug therapy,and group B received Buchangwenbxin particles with routine drug therapy.Another 54 elder patients with diastolic cardiac function but without PAF was selected as control group.Changes in Pmax and Pd were compared between groups with or without PAF as well as subgroups.Results Pmax and Pd were wider in PAF group than no PAF group(all P ＜0.01).There was no difference between group A and B in Pmax and Pd (all P＞ 0.05), and there were less atrial fibrillation as well as shortened Pmax and Pd in group B, which was significantly different with group A(all P ＜0.01).Conclusion Pmax and Pd were wider in elder patients with diastolic cardiac dysfunction and PAF than those without PAF,and Buchangwenxin particles could shorten Pmax and Pd and reduce the attacks of atrial fibrillation.
